Multi-Features Disease Analysis Based Smart Diagnosis for COVID-19

Coronavirus 2019 (COVID -19) is the current global buzzword, putting the world at risk. The pandemic's exponential expansion of infected COVID-19 patients has challenged the medical field's resources, which are already few. Even established nations would not be in a perfect position to manage this epidemic correctly, leaving emerging countries and countries that have not yet begun to grow to address the problem. These problems can be solved by using machine learning models in a realistic way, such as by using computer-aided images during medical examinations. These models help predict the effects of the disease outbreak and help detect the effects in the coming days. In this paper, Multi-Features Decease Analysis (MFDA) is used with different ensemble classifiers to diagnose the disease's impact with the help of Computed Tomography (CT) scan images. There are various features associated with chest CT images, which help know the possibility of an individual being affected and how COVID-19 will affect the persons suffering from pneumonia. The current study attempts to increase the precision of the diagnosis model by evaluating various feature sets and choosing the best combination for better results. The model's performance is assessed using Receiver Operating Characteristic (ROC) curve, the Root Mean Square Error (RMSE), and the Confusion Matrix. It is observed from the resultant outcome that the performance of the proposed model has exhibited better efficient. © 2023 CRL Publishing. All rights reserved.

Real-Time Health Monitoring System Using Predictive Analytics

Medical specialists are primarily interested in researching health care as a potential replacement for conventional healthcare methods nowadays. COVID-19 creates chaos in society regardless of the modern technological evaluation involved in this sector. Due to inadequate medical care and timely, accurate prognoses, many unexpected fatalities occur. As medical applications have expanded in their reaches along with their technical revolution, therefore patient monitoring systems are getting more popular among the medical actors. The Internet of Things (IoT) has met the requirements for the solution to deliver such a vast service globally at any time and in any location. The suggested model shows a wearable sensor node that the patients will wear. Monitoring client metrics like blood pressure, heart rate, temperature, etc., is the responsibility of the sensor nodes, which send the data to the cloud via an intermediary node. The sensor-acquired data are stored in the cloud storage for detailed analysis. Further, the stored data will be normalized and processed across various predictive models. Among the different cloud-based predictive models now being used, the model having the highest accuracy will be treated as the resultant model. This resultant model will be further used for the data dissemination mechanism by which the concerned medical actors will be provided an alert message for a proper medication in a desirable manner. © 2023, The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

Multi-Features Disease Analysis Based Smart Diagnosis for COVID-19

Coronavirus 2019 (COVID -19) is the current global buzzword, putting the world at risk. The pandemic’s exponential expansion of infected COVID-19 patients has challenged the medical field’s resources, which are already few. Even established nations would not be in a perfect position to manage this epidemic correctly, leaving emerging countries and countries that have not yet begun to grow to address the problem. These problems can be solved by using machine learning models in a realistic way, such as by using computer-aided images during medical examinations. These models help predict the effects of the disease outbreak and help detect the effects in the coming days. In this paper, Multi-Features Decease Analysis (MFDA) is used with different ensemble classifiers to diagnose the disease’s impact with the help of Computed Tomography (CT) scan images. There are various features associated with chest CT images, which help know the possibility of an individual being affected and how COVID-19 will affect the persons suffering from pneumonia. The current study attempts to increase the precision of the diagnosis model by evaluating various feature sets and choosing the best combination for better results. The model’s performance is assessed using Receiver Operating Characteristic (ROC) curve, the Root Mean Square Error (RMSE), and the Confusion Matrix. It is observed from the resultant outcome that the performance of the proposed model has exhibited better efficient. © 2023 CRL Publishing. All rights reserved.

Shallow Net for COVID-19 Classification based on Biomarkers

In many cases, especially at the beginning of epidemic disaster, it is very important to be able to determine the severity of illness of a given patient. Picking up the severe status will help in directing the effort in a proper way. At the beginning, the number of classified status and the available data are limited, so, in such situation, one needs a system that can be trained based on limited data to give a trusted result. The current work focuses on the importance of the bioscience in differentiation between recovered patients and mortalities. Even with limited data, the decision trees (DT) was able to distinguish between recovered patients and mortalities with accuracy of 94%. Shallow dense network achieved accuracy of 75%. However, when a 10-fold technique was followed with the same data, the net achieved 99% of accuracy. The used data in this work was collected from King Faisal hospital in Taif city under a formal permission from the health ministry. PCA analysis confirmed that there are two parameters that have the greatest ability to differentiate between recovered patients and mortalities. ROC curve reveals that the parameters that can differentiate between recovered patients and mortalities are calcium and hemoglobin. The shallow net gives an accuracy of 92% when trained using calcium and hemoglobin only. This paper shows that with a suitable choosing of the parameters a small decision tree or shallow net can be trained quickly to decide which patient needs more attention so as to use the hospitals resources in a more reasonable way during the pandemic. All codes and data can be accessed from the following link “codes and data” © 2022. International Journal of Advanced Computer Science and Applications.All Rights Reserved.

Utility of a Pulmonary Oedema Score for Predicting the Need for Mechanical Ventilation in COVID-19 Patients in a General Hospital.

BACKGROUND: The Radiographic Assessment of Lung Edema (RALE) score has been used to estimate the extent of pulmonary damage in patients with acute respiratory distress syndrome and might be useful in patients with COVID-19. AIM OF THE STUDY: To examine factors associated with the need for mechanical ventilation in hospitalized patients with a clinical diagnosis of COVID-19, and to estimate the predictive value of the RALE score. METHODS: In a series of patients admitted between April 14 and August 28, 2020, with a clinical diagnosis of COVID-19, we assessed lung involvement on the chest radiograph using the RALE score. We examined factors associated with the need for mechanical ventilation in bivariate and multivariate analysis. The area under the receiver operating curve (AUC) indicated the predictive value of the RALE score for need for mechanical ventilation. RESULTS: Among 189 patients, 90 (48%) were judged to need mechanical ventilation, although only 60 were placed on a ventilator. The factors associated with the need for mechanical ventilation were a RALE score >6 points, age >50 years, and presence of chronic kidney disease. The AUC for the RALE score was 60.9% (95% CI 52.9-68.9), indicating it was an acceptable predictor of needing mechanical ventilation. CONCLUSIONS: A score for extent of pulmonary oedema on the plain chest radiograph was a useful predictor of the need for mechanical ventilation of hospitalized patients with COVID-19.